Brief: Veracyte Q4 Revenue USD 98.2 Million Vs. IBES Estimate USD 92 Million
22/02/2024 21:05
Feb 22 (Reuters) - Veracyte Q4 net income USD -28.3 million. * Q4 gross margin 66% * outlook FY revenue USD 394-402 million
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina